Startups
Peptomyc focuses on the development of a new generation of cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.
Summary
43
Industry
Total funding Amount
$27M
Fundraising History
-
Dec 01 '20 Unknown$14M
Investors
-
HealthequityUnknown